Related references
Note: Only part of the references are listed.Population-Based Study of Bloodstream Infection Incidence and Mortality Rates, Finland, 2004-2018
Keiju S. K. Kontula et al.
EMERGING INFECTIOUS DISEASES (2021)
Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program
Lukas Richter et al.
PLOS ONE (2019)
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination
Germaine Hanquet et al.
THORAX (2019)
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study
Shamez N. Ladhani et al.
LANCET INFECTIOUS DISEASES (2018)
Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland
Hanna Rinta-Kokko et al.
VACCINE (2018)
Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium
Lander Willem et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Establishing and maintaining the National Vaccination Register in Finland
U. Baum et al.
EUROSURVEILLANCE (2017)
Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations (Publication with Expression of Concern. See vol. 68, pg. 534, 2019)
Pontus Naucler et al.
CLINICAL INFECTIOUS DISEASES (2017)
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
Pauline A. Waight et al.
LANCET INFECTIOUS DISEASES (2015)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R. Moore et al.
LANCET INFECTIOUS DISEASES (2015)
Preventing pneumococcal infections in older adults
Pekka Nuorti et al.
LANCET RESPIRATORY MEDICINE (2015)
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
Mirjam J. Knol et al.
EMERGING INFECTIOUS DISEASES (2015)
Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality
Zitta Barrella Harboe et al.
CLINICAL INFECTIOUS DISEASES (2014)
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
Nick J. Andrews et al.
LANCET INFECTIOUS DISEASES (2014)
Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada
Philippe De Wals et al.
VACCINE (2014)
Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
Ron Dagan et al.
CLINICAL INFECTIOUS DISEASES (2013)
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
Arto A. Palmu et al.
LANCET (2013)
Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
Anneke Steens et al.
VACCINE (2013)
Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
Daniel R. Feikin et al.
PLOS MEDICINE (2013)
From Quellung to Multiplex PCR, and Back When Needed, in Pneumococcal Serotyping
Lotta Siira et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Effect of Serotype on Focus and Mortality of Invasive Pneumococcal Disease: Coverage of Different Vaccines and Insight into Non-Vaccine Serotypes
Albert Jan van Hoek et al.
PLOS ONE (2012)
Serotype replacement in disease after pneumococcal vaccination
Daniel M. Weinberger et al.
LANCET (2011)
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
Elizabeth Miller et al.
LANCET INFECTIOUS DISEASES (2011)
Temporal Trends in Invasive Pneumococcal Disease and Pneumococcal Serotypes over 7 Decades
Zitta B. Harboe et al.
CLINICAL INFECTIOUS DISEASES (2010)
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Tamara Pilishvili et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Invasive pneumococcal infections among persons with and without underlying medical conditions:: Implications for prevention strategies
Peter Klemets et al.
BMC INFECTIOUS DISEASES (2008)
Share Paper
